NO20063279L - Fremgangsmater og sammensetninger til behandling av lipodystrofi - Google Patents
Fremgangsmater og sammensetninger til behandling av lipodystrofiInfo
- Publication number
- NO20063279L NO20063279L NO20063279A NO20063279A NO20063279L NO 20063279 L NO20063279 L NO 20063279L NO 20063279 A NO20063279 A NO 20063279A NO 20063279 A NO20063279 A NO 20063279A NO 20063279 L NO20063279 L NO 20063279L
- Authority
- NO
- Norway
- Prior art keywords
- lipodystrophy
- treatment
- methods
- compositions
- hiv
- Prior art date
Links
- 206010049287 Lipodystrophy acquired Diseases 0.000 title abstract 4
- 208000006132 lipodystrophy Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54020404P | 2004-01-29 | 2004-01-29 | |
| US54336604P | 2004-02-10 | 2004-02-10 | |
| PCT/EP2005/000758 WO2005074916A1 (en) | 2004-01-29 | 2005-01-26 | Methods and compositions for the treatment of lipodystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063279L true NO20063279L (no) | 2006-09-19 |
Family
ID=34841102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063279A NO20063279L (no) | 2004-01-29 | 2006-07-14 | Fremgangsmater og sammensetninger til behandling av lipodystrofi |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1722778A1 (ko) |
| JP (1) | JP2007519669A (ko) |
| KR (1) | KR20060127977A (ko) |
| AU (1) | AU2005210093A1 (ko) |
| BR (1) | BRPI0507302A (ko) |
| CA (1) | CA2552404A1 (ko) |
| EA (1) | EA200601392A1 (ko) |
| IL (1) | IL176762A0 (ko) |
| NO (1) | NO20063279L (ko) |
| WO (1) | WO2005074916A1 (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2903312B1 (fr) | 2006-07-05 | 2008-09-26 | Univ Aix Marseille Ii | Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament |
| BRPI0821962A2 (pt) * | 2008-01-03 | 2019-05-07 | Univ De La Mediterrannee Aix Marseille Ii | composições e métodos usados durante um tratamento anti-hiv |
| EP2421548A4 (en) * | 2009-04-20 | 2012-09-26 | Theratechnologies Inc | USE OF (HEXENOYL-TRANS-3) HGRF (L-44) NH2 AND SIMVASTATIN IN COMBINATION THERAPY |
| US20170065678A1 (en) * | 2014-03-11 | 2017-03-09 | Novartis Ag | Methods of treating metabolic disorders associated with lipodystrophies and defects in insulin production or signaling |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9803623D0 (sv) * | 1998-10-22 | 1998-10-22 | Sahltech Ab | New therapeutic application |
-
2005
- 2005-01-26 KR KR1020067016376A patent/KR20060127977A/ko not_active Application Discontinuation
- 2005-01-26 WO PCT/EP2005/000758 patent/WO2005074916A1/en active Application Filing
- 2005-01-26 CA CA002552404A patent/CA2552404A1/en not_active Abandoned
- 2005-01-26 AU AU2005210093A patent/AU2005210093A1/en not_active Abandoned
- 2005-01-26 JP JP2006550092A patent/JP2007519669A/ja active Pending
- 2005-01-26 EA EA200601392A patent/EA200601392A1/ru unknown
- 2005-01-26 EP EP05707019A patent/EP1722778A1/en not_active Withdrawn
- 2005-01-26 BR BRPI0507302-2A patent/BRPI0507302A/pt not_active IP Right Cessation
-
2006
- 2006-07-10 IL IL176762A patent/IL176762A0/en unknown
- 2006-07-14 NO NO20063279A patent/NO20063279L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL176762A0 (en) | 2006-10-31 |
| EP1722778A1 (en) | 2006-11-22 |
| AU2005210093A1 (en) | 2005-08-18 |
| BRPI0507302A (pt) | 2007-06-26 |
| CA2552404A1 (en) | 2005-08-18 |
| KR20060127977A (ko) | 2006-12-13 |
| JP2007519669A (ja) | 2007-07-19 |
| EA200601392A1 (ru) | 2006-12-29 |
| WO2005074916A1 (en) | 2005-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006068729A3 (en) | Methods and compositions for enhancing iron absorption | |
| WO2008030505A3 (en) | Methods and compositions for the treatment of antibody mediated neuropathies | |
| WO2009115652A3 (fr) | Bi- et tri-therapie utilisables lors du traitement d' un patient infecte par le vih | |
| MY165570A (en) | Inhibitors of poly (adp-ribose) polymerase | |
| MX2009013349A (es) | Compuestos quimicos. | |
| MX2009004038A (es) | Gel de diclofenaco. | |
| MX2007003095A (es) | Metodos y dispositivos para cerrar los vasos sanguineos inducidos electricamente no termicos. | |
| WO2007120626A3 (en) | Uses and compositions for treatment of ankylosing spondylitis | |
| NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
| NO20075304L (no) | Metode for avtagende forkalkning | |
| EP1670450B8 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
| TW200716224A (en) | Method of indentifying therapeutic targets for the treatment of vulvovaginal atrophy | |
| MX350046B (es) | Tratamientos para trastornos gastrointestinales. | |
| WO2008118849A3 (en) | Hiv-1 protease inhibitors | |
| ATE541848T1 (de) | Diaryl-purin, azapurine und deazapurine als nichtnukleoside reverse-transkriptase-inhibitoren zur behandlung von hiv | |
| TW200716088A (en) | Formulations and methods for treating amyloidosis | |
| WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
| NO20075764L (no) | Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen | |
| MX2022001004A (es) | Inhibidores de enzimas. | |
| TW200738700A (en) | HIV integrase inhibitors | |
| CY1108599T1 (el) | Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος | |
| NO20063279L (no) | Fremgangsmater og sammensetninger til behandling av lipodystrofi | |
| MX2009011930A (es) | Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c. | |
| EA201200428A1 (ru) | Композиция и способ для лечения ожирения | |
| EP3939599A3 (en) | Silicate containing compositions and methods of treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |